AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389 | +20.8% | 5,560 | +23.9% | 0.00% | 0.0% |
| Q2 2023 | $322 | +49.1% | 4,487 | +60.0% | 0.00% | 0.0% |
| Q4 2022 | $216 | -99.9% | 2,805 | -51.0% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | +3.5% | 5,722 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $229,000 | -67.8% | 6,049 | -42.6% | 0.00% | -66.7% |
| Q2 2021 | $711,000 | +25.2% | 10,540 | +5.0% | 0.00% | 0.0% |
| Q1 2021 | $568,000 | -30.0% | 10,040 | +0.9% | 0.00% | -25.0% |
| Q4 2020 | $811,000 | +18.0% | 9,955 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $687,000 | -22.5% | 9,643 | -10.5% | 0.00% | -33.3% |
| Q2 2020 | $886,000 | +80.1% | 10,772 | +28.9% | 0.01% | +50.0% |
| Q1 2020 | $492,000 | -78.7% | 8,356 | -62.6% | 0.00% | -73.3% |
| Q4 2019 | $2,311,000 | +301.2% | 22,360 | -21.5% | 0.02% | +275.0% |
| Q3 2019 | $576,000 | -18.8% | 28,475 | +3.5% | 0.00% | -20.0% |
| Q2 2019 | $709,000 | +183.6% | 27,525 | +56.6% | 0.01% | +150.0% |
| Q1 2019 | $250,000 | – | 17,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |